Structure-based design of an urokinase-type plasminogen activator receptor-derived peptide inhibiting cell migration and lung metastasis.
Carriero MV, Longanesi-Cattani I, Bifulco K, Maglio O, Lista L, Barbieri A, Votta G, Masucci MT, Arra C, Franco R, De Rosa M, Stoppelli MP, Pavone V.
Mol Cancer Ther. 2009 Sep;8(9):2708-17. Epub 2009 Aug 25.PMID: 19706734 [PubMed - in process]Related articles